COMP <GO>
CVSA vs BN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Covista Inc. (NYSE) VS. Brookfield Corporation Class A Limited Voting Shares (NYSE) • 15-METRIC TALLY: CVSA 11
— BN 3
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: BN
LAST: $124.33 (-3.44%) • MKT CAP: $4.36B
options-implied-move
7.10%
LAST: $39.28 (-0.56%) • MKT CAP: $96.80B
options-implied-move
6.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVSA VS. BN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVSA | BN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.90% | 41.00% | +15.90 | CVSA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.80% | 9.90% | +4.90 | CVSA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.5x | 21.0x | -8.50 | CVSA | /valuation <GO> |
| Free Cash Flow Yield | 6.60% | 2.21% | +4.39 | CVSA | /fcf-yield <GO> |
| Operating Margin | 19.10% | 13.90% | +5.20 | CVSA | /operating-margins <GO> |
| Net Profit Margin | 13.30% | 10.90% | +2.40 | CVSA | /net-margins <GO> |
| Revenue Growth (YoY) | 12.90% | -1.10% | +14.00 | CVSA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.40% | 3.40% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.73 | 3.74 | +0.99 | CVSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | CVSA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.10% | 6.50% | +0.60 | BN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.0 | 63.6 | -20.61 | BN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.88 | +0.17 | CVSA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.5x | 30.5x | -15.00 | CVSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.36B | $96.80B | -$92.44B | BN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVSA REV | BN REV | CVSA GROSS % | BN GROSS % | CVSA FCF | BN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.79B | — | 56.9% | — | $287.6M | — |
| FY 2024 | $1.58B | — | 55.9% | — | $246.9M | — |
| FY 2023 | $1.45B | — | 44.0% | — | $126.6M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVSA // BETA 1.05
BN // BETA 0.88